title: Advances in ovarian cancer screening: health and medicine for women: a multidisciplinary, evidence-based review of mid-life health concerns.
abstract: Early detection is imperative for improving survival from ovarian cancer, the leading cause of death from gynecological cancer in the United States. At the Health and Medicine for Women continuing medical education (CME) conference at Yale in September 2010, Dr. Gil Mor, a researcher in the Department of OB/GYN at Yale, presented recent advances on the pathophysiology of ovarian cancer. These advances, and particularly our growing understanding of cancer stem cells, may help overcome the limitations of current ovarian cancer detection and treatment methods.
authors: Yale University School of Medicine, New Haven, Connecticut, USA. sumayya.ahmad@yale.edu
authors: Sumayya
authors: S
authors: Ahmad
mesh_terms: D000818:Animals; D003226:Congresses as Topic; D055088:Early Detection of Cancer / Q000379:methods*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D008875:Middle Aged; D014411:Neoplastic Stem Cells / Q000502:physiology; D010051:Ovarian Neoplasms / Q000175:diagnosis* / Q000473:pathology; D016387:Women's Health